Cargando…

Recombinant activated factor VII: does it really save lives?

Detalles Bibliográficos
Autor principal:	Edke, U
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4084315/ http://dx.doi.org/10.1186/cc7593

Ejemplares similares

Treatment of obstetric hemorrhage with recombinant activated factor VII
por: Czuprynski, P, et al.
Publicado: (2009)

Activated recombinant factor VII in management of bleeding in patients with thrombocytopenia
por: Shulutko, E, et al.
Publicado: (2006)

Safety of activated recombinant factor VII in patients with circulatory assist devices
por: Schneider, AS, et al.
Publicado: (2009)

Use of recombinant activated factor VII after paediatric cardiac surgery
por: Kharkin, A, et al.
Publicado: (2006)

Guidelines-associated decrease in mortality with recombinant activated factor VII for refractory hemorrhage
por: Schneider, AS, et al.
Publicado: (2009)

Recombinant activated factor VII for the treatment of bleeding in abdominal surgery and cardiac surgery
por: Michalska, G, et al.
Publicado: (2009)

Efficacy of recombinant activated factor VII in the management of severe hemorrhage following cardiac surgery
por: Trecova, N, et al.
Publicado: (2006)

Two years experience with low-dose recombined activated factor VII treatment of non-haemophilic patients
por: Michalska, G, et al.
Publicado: (2006)

AIMing to save lives
por: Berry, A, et al.
Publicado: (2008)

Analysis of the off-licence use of recombinant activated factor VII for patients with uncontrolled haemorrhage in a UK tertiary referral hospital
por: Spivey, M, et al.
Publicado: (2009)

Evaluation of the role of recombinant activated factor VII (NovoSeven) as a rescue haemostatic therapy in postcardiopulmonary bypass surgical patients
por: Chen, Z, et al.
Publicado: (2007)

Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany
por: Rossaint, R, et al.
Publicado: (2006)

Decannulation: in the ICU or in the ward? Does it really matter?
por: Milercy, O, et al.
Publicado: (2011)

Source of ICU admission: does it really matter?
por: Datta, A, et al.
Publicado: (2015)

Recombinant activated factor VII treatment of severe bleeding in cardiac surgery patients: a retrospective analysis of dosing, and efficacy and safety outcomes
por: Liebl, M, et al.
Publicado: (2007)

Outcome after CPR: when we cannot save lives, we can save organs
por: Caestecker, C, et al.
Publicado: (2015)

Staying home saves lives, really!
por: Malpede, Maurizio, et al.
Publicado: (2022)

Wash your hands: simple measures save lives
por: Macedo, S, et al.
Publicado: (2012)

Implementation of the protocol of decompressive craniectomy: does it really improve outcome?
por: Missaka, H, et al.
Publicado: (2009)

Infliximab in the treatment of refractory uveitis. Does dose really matter?
por: Sukumaran, MD Sukesh, et al.
Publicado: (2011)

Factor VII for intractable bleeding after cardiac surgery
por: Kogan, A, et al.
Publicado: (2007)

Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven(®)) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial
por: Thabut, D, et al.
Publicado: (2004)

The use of activated recombinant coagulation factor VII in patients undergoing major reconstruction surgery for traumatic fracture pelvis or pelvis and acetabulum: a double-blind, randomised, placebo-controlled trial
por: Raobaikady, R, et al.
Publicado: (2005)

Does the coagulation profile really matter in central venous cannulation? A review of the literature
por: Baombe, J, et al.
Publicado: (2011)

Is this admission really relevant?
por: Folkestad, Lars, et al.
Publicado: (2009)

Left ventricular hypertrophy: is it really?
por: Mikolich, J Ronald, et al.
Publicado: (2013)

Severe asthma is really uncommon
por: Zicari, Anna Maria, et al.
Publicado: (2013)

Effectiveness and safety of recombinant activated factor
por: Echarri González, G, et al.
Publicado: (2006)

Saving 500 Lives Campaign: another way to improve the mortality rate of patients with severe sepsis and septic shock
por: Champunot, R, et al.
Publicado: (2012)

Impact of the involvement of hospitals in Benin in the actions of the world program “Save Lives: Clean Your Hands» edition 2014
por: Ahoyo, TA, et al.
Publicado: (2015)

Are phenylcarboxylic acids really markers in severe sepsis?
por: Beloborodova, NV, et al.
Publicado: (2009)

Specific PKG inhibitors: do they really exist?
por: Gambaryan, Stepan, et al.
Publicado: (2011)

Does intensive insulin therapy really reduce the incidence of acute renal injury in critically ill patients? An analysis using the rifle criteria
por: Azevedo, JRA, et al.
Publicado: (2009)

Early transfer of cases from emergency(ER) to ICU (≤1 hour) - does it really make a big difference in outcome? an analysis
por: Kar, A, et al.
Publicado: (2015)

The role of recombinant activated factor VII in cardiac surgery
por: Richardson, A, et al.
Publicado: (2009)

Overview of the human pharmacokinetics of recombinant activated factor VII
por: Klitgaard, Thomas, et al.
Publicado: (2008)

Recombinant activated factor VII in post partum haemorrhage
por: Magon, Navneet, et al.
Publicado: (2013)

Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®))
por: Bartosh, Nicole S, et al.
Publicado: (2013)

Admission to the ICU overnight: is it really a bad thing?
por: Adams, M, et al.
Publicado: (2013)

Anemia in children with JIA: is it really driven by hepcidin level, or by a set of factors of a chronic disease
por: Egorov, Andrey, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_taci4hop1u66vaptfr5buvauei